Note 15. Net Loss Per Share Basic and diluted net loss per share are as follows: | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | June 30, | | June 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | | | | | | | | | | | | | Net loss (numerator) | | $ | (19,187) | | $ | (8,299) | | $ | (26,441) | | $ | (35,090) | Weighted average shares (denominator) | | | 7,843 | | | 2,516 | | | 6,347 | | | 2,223 | Basic and diluted net loss per share | | $ | (2.45) | | $ | (3.30) | | $ | (4.17) | | $ | (15.78) |
Potentially dilutive securities outstanding consists of stock options, RSUs and performance units, and BTI warrants. The Company had common stock equivalents outstanding are as follows: | | | | | | | | | | As of | | | | June 30, | | | | 2025 | | 2024 | | | | | | | | | | Stock options | | | 351 | | | 302 | | Restricted stock units | | | 77 | | | 8 | | Performance stock units | | | 57 | | | 27 | | BTI Warrants | | | 5,479 | | | 567 | | Total common stock equivalents | | | 5,964 | | | 904 | |
|